IBD serology was positive for anti‐OmpC IgA, IBD‐specific pANCA, and ASCA IgA; and genetic mutations in ATG16L1, ECM1, and NKX2‐3 linked to CD were identified. This evidence concerns the gene ECM1 and inflammatory bowel disease.